ConductScience.org, home

Disease · MONDO_0001577

Targets35

The targets ChEMBL's mechanism records give for the disease's drugs, through Open Targets, the most drugs first. A mechanism record says what a drug acts on, not that the target causes the disease.

TargetProteinIts drugs that act on itMechanismsHighest stage of those drugsGene in GenesSource
ADRA1AAdrenergic receptor1Adrenergic receptor agonistUnknownhttps://conductscience.org/library/genes/148Drugs and targets
ADRA1BAdrenergic receptor1Adrenergic receptor agonistUnknownhttps://conductscience.org/library/genes/147Drugs and targets
ADRA1DAdrenergic receptor1Adrenergic receptor agonistUnknownhttps://conductscience.org/library/genes/146Drugs and targets
ADRA2AAdrenergic receptor1Adrenergic receptor agonistUnknownhttps://conductscience.org/library/genes/150Drugs and targets
ADRA2BAdrenergic receptor1Adrenergic receptor agonistUnknownhttps://conductscience.org/library/genes/151Drugs and targets
ADRA2CAdrenergic receptor1Adrenergic receptor agonistUnknownhttps://conductscience.org/library/genes/152Drugs and targets
ADRB1Adrenergic receptor1Adrenergic receptor agonistUnknownhttps://conductscience.org/library/genes/153Drugs and targets
ADRB2Adrenergic receptor1Adrenergic receptor agonistUnknownhttps://conductscience.org/library/genes/154Drugs and targets
ADRB3Adrenergic receptor1Adrenergic receptor agonistUnknownhttps://conductscience.org/library/genes/155Drugs and targets
CCR2C-C chemokine receptor type 21C-C chemokine receptor type 2 inhibitorUnknownhttps://conductscience.org/library/genes/729230Drugs and targets
CXCR2C-X-C chemokine receptor type 21Interleukin-8 receptor B antagonistPhase 1https://conductscience.org/library/genes/3579Drugs and targets
GABRA1GABA-A receptor; anion channel1GABA-A receptor; anion channel positive allosteric modulatorUnknownhttps://conductscience.org/library/genes/2554Drugs and targets
GABRA2GABA-A receptor; anion channel1GABA-A receptor; anion channel positive allosteric modulatorUnknownhttps://conductscience.org/library/genes/2555Drugs and targets
GABRA3GABA-A receptor; anion channel1GABA-A receptor; anion channel positive allosteric modulatorUnknownhttps://conductscience.org/library/genes/2556Drugs and targets
GABRA4GABA-A receptor; anion channel1GABA-A receptor; anion channel positive allosteric modulatorUnknownhttps://conductscience.org/library/genes/2557Drugs and targets
GABRA5GABA-A receptor; anion channel1GABA-A receptor; anion channel positive allosteric modulatorUnknownhttps://conductscience.org/library/genes/2558Drugs and targets
GABRA6GABA-A receptor; anion channel1GABA-A receptor; anion channel positive allosteric modulatorUnknownhttps://conductscience.org/library/genes/2559Drugs and targets
GABRB1GABA-A receptor; anion channel1GABA-A receptor; anion channel positive allosteric modulatorUnknownhttps://conductscience.org/library/genes/2560Drugs and targets
GABRB2GABA-A receptor; anion channel1GABA-A receptor; anion channel positive allosteric modulatorUnknownhttps://conductscience.org/library/genes/2561Drugs and targets
GABRB3GABA-A receptor; anion channel1GABA-A receptor; anion channel positive allosteric modulatorUnknownhttps://conductscience.org/library/genes/2562Drugs and targets

diseases-2026-09-18-0.1.0

Sources 6

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • NLM's MeSHNLM's terms
  • Open TargetsCC0 1.0
  • PubMedNLM's terms
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • NLM's MeSHNLM's
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PubMedNLM's terms

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this list from software.

Twenty rows a page, as JSON. No key.

GET https://conductscience.org/api/diseases/v1/MONDO_0001577/targets